Seer outlines $13.5M-$14.5M 2026 revenue outlook while refocusing commercial efforts after special committee review (NASDAQ:SEER)November 11, 2026
Cumberland outlines plan to fund operations for over 5 years as it prepares rolling NDA submission for ifetroban in DMD (NASDAQ:CPIX)November 10, 2026
Share Facebook Twitter LinkedIn Pinterest Email Life360 GAAP EPS of $0.26 beats by $0.17, revenue of $174.1M beats by $2.69M
Seer outlines $13.5M-$14.5M 2026 revenue outlook while refocusing commercial efforts after special committee review (NASDAQ:SEER)November 11, 2026
Cumberland outlines plan to fund operations for over 5 years as it prepares rolling NDA submission for ifetroban in DMD (NASDAQ:CPIX)November 10, 2026
By Press Room
By Press Room
By Press Room
